CLIMB BIO, INC. Increase (Decrease) in Prepaid Expenses, Other
CLIMB BIO, INC. (CLYM) reported Increase (Decrease) in Prepaid Expenses, Other of -$1.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-06
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was -$327.00K, a 152.66% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$929.00K.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $706.00K.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $1.38M, a 38.76% increase year-over-year.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was $816.00K.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$1.94M.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$7.37M.
- CLIMB BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$945.00K, a 109.21% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.26M 10-Q · filed 2026-08-06 | -$550.00K derived: sum of 3 quarters · filed 2026-08-06 | $832.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$929.00K 10-Q · filed 2026-05-07 | -$223.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.16M derived: sum of 3 quarters · filed 2026-05-07 | $1.78M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.09M derived: sum of 2 quarters · filed 2026-03-05 | $2.71M derived: sum of 3 quarters · filed 2026-08-06 | $816.00K 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.00M derived: sum of 2 quarters · filed 2026-08-06 | $110.00K 10-Q · filed 2025-11-06 | -$403.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.27M 10-Q · filed 2026-08-06 | -$1.78M derived: sum of 3 quarters · filed 2026-08-06 | -$789.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$1.89M 10-Q · filed 2026-05-07 | -$2.41M derived: sum of 2 quarters · filed 2026-05-07 | -$1.41M derived: sum of 3 quarters · filed 2026-05-07 | -$3.62M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $483.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.73M derived: sum of 3 quarters · filed 2026-03-05 | -$1.94M 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $996.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.21M derived: sum of 2 quarters · filed 2025-11-06 | -$1.43M 10-Q · filed 2025-11-06 | -$2.97M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.42M 10-Q · filed 2025-08-12 | -$3.97M derived: sum of 3 quarters · filed 2025-08-12 | -$10.58M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$216.00K 10-Q · filed 2025-05-14 | -$1.76M derived: sum of 2 quarters · filed 2025-05-14 | -$8.37M derived: sum of 3 quarters · filed 2025-05-14 | -$7.56M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$8.15M derived: sum of 2 quarters · filed 2025-03-25 | -$7.34M derived: sum of 3 quarters · filed 2025-03-25 | -$7.37M 10-K · filed 2025-03-25 | ||
| 2023-09-30 | -$6.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.80M derived: sum of 2 quarters · filed 2024-11-12 | -$5.83M 10-Q · filed 2024-11-12 | -$5.55M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $809.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $784.00K 10-Q · filed 2024-08-14 | $1.06M derived: sum of 3 quarters · filed 2024-08-14 | $1.49M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-15 | $249.00K derived: sum of 2 quarters · filed 2024-05-15 | $676.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.46M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $701.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.49M derived: sum of 3 quarters · filed 2024-03-28 | -$945.00K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.21M derived: sum of 2 quarters · filed 2023-11-14 | -$1.22M 10-Q · filed 2023-11-14 | -$2.06M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.65M 10-Q · filed 2023-08-10 | -$2.49M derived: sum of 3 quarters · filed 2023-08-10 | $4.80M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$2.43M 10-Q · filed 2023-05-11 | -$3.27M derived: sum of 2 quarters · filed 2023-05-11 | $4.02M derived: sum of 3 quarters · filed 2023-05-11 | $7.35M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $6.45M derived: sum of 2 quarters · filed 2023-03-06 | $9.78M derived: sum of 3 quarters · filed 2023-03-06 | $10.26M 10-K · filed 2023-03-06 | -$10.26M 10-K · filed 2022-03-07 | |
| 2021-09-30 | $7.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $10.62M derived: sum of 2 quarters · filed 2022-11-14 | $11.10M 10-Q · filed 2022-11-14 | -$11.10M 10-Q · filed 2021-11-08 | $7.52M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $3.81M 10-Q · filed 2022-08-15 | $223.00K derived: sum of 3 quarters · filed 2022-08-15 | $634.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $481.00K 10-Q · filed 2022-05-16 | -$3.11M derived: sum of 2 quarters · filed 2022-05-16 | -$2.69M derived: sum of 3 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$3.18M derived: sum of 2 quarters · filed 2022-03-07 | -$1.35M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.23M 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | $1.82M 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |